Oesophageal atresia

Marinde van Lennep, Maartje M. J. Singendonk, Luigi Dall’Oglio, Fréderic Gottrand, Usha Krishnan, Suzanne W. J. Terheggen-Lagro, Taher I. Omari, Marc A. Benninga, Michiel P. van Wijk

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated birth defects or anomalies, such as VACTERL association, trisomy 18 or 21 and CHARGE syndrome, occur in the majority of patients born with EA. Although several studies have revealed signalling pathways and genes potentially involved in the development of EA, our understanding of the pathophysiology of EA lags behind the improvements in surgical and clinical care of patients born with this anomaly. EA is treated surgically to restore the oesophageal interruption and, if present, ligate and divide the TEF. Survival is now ~90% in those born with EA with severe associated anomalies and even higher in those born with EA alone. Despite these achievements, long-term gastrointestinal and respiratory complications and comorbidities in patients born with EA are common and lead to decreased quality of life. Oesophageal motility disorders are probably ubiquitous in patients after undergoing EA repair and often underlie these complications and comorbidities. The implementation of several new diagnostic and screening tools in clinical care, including high-resolution impedance manometry, pH-multichannel intraluminal impedance testing and disease-specific quality of life questionnaires now provide better insight into these problems and may contribute to better long-term outcomes in the future.
LanguageEnglish
Article number26
JournalNATURE REVIEWS DISEASE PRIMERS
Volume5
Issue number1
DOIs
Publication statusPublished - 2019

Cite this

van Lennep, M., Singendonk, M. M. J., Dall’Oglio, L., Gottrand, F., Krishnan, U., Terheggen-Lagro, S. W. J., ... van Wijk, M. P. (2019). Oesophageal atresia. NATURE REVIEWS DISEASE PRIMERS, 5(1), [26]. https://doi.org/10.1038/s41572-019-0077-0
van Lennep, Marinde ; Singendonk, Maartje M. J. ; Dall’Oglio, Luigi ; Gottrand, Fréderic ; Krishnan, Usha ; Terheggen-Lagro, Suzanne W. J. ; Omari, Taher I. ; Benninga, Marc A. ; van Wijk, Michiel P. / Oesophageal atresia. In: NATURE REVIEWS DISEASE PRIMERS. 2019 ; Vol. 5, No. 1.
@article{8b964562fa9e46af93bf3a6363a9d0bd,
title = "Oesophageal atresia",
abstract = "Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated birth defects or anomalies, such as VACTERL association, trisomy 18 or 21 and CHARGE syndrome, occur in the majority of patients born with EA. Although several studies have revealed signalling pathways and genes potentially involved in the development of EA, our understanding of the pathophysiology of EA lags behind the improvements in surgical and clinical care of patients born with this anomaly. EA is treated surgically to restore the oesophageal interruption and, if present, ligate and divide the TEF. Survival is now ~90{\%} in those born with EA with severe associated anomalies and even higher in those born with EA alone. Despite these achievements, long-term gastrointestinal and respiratory complications and comorbidities in patients born with EA are common and lead to decreased quality of life. Oesophageal motility disorders are probably ubiquitous in patients after undergoing EA repair and often underlie these complications and comorbidities. The implementation of several new diagnostic and screening tools in clinical care, including high-resolution impedance manometry, pH-multichannel intraluminal impedance testing and disease-specific quality of life questionnaires now provide better insight into these problems and may contribute to better long-term outcomes in the future.",
author = "{van Lennep}, Marinde and Singendonk, {Maartje M. J.} and Luigi Dall’Oglio and Fr{\'e}deric Gottrand and Usha Krishnan and Terheggen-Lagro, {Suzanne W. J.} and Omari, {Taher I.} and Benninga, {Marc A.} and {van Wijk}, {Michiel P.}",
year = "2019",
doi = "10.1038/s41572-019-0077-0",
language = "English",
volume = "5",
journal = "NATURE REVIEWS DISEASE PRIMERS",
issn = "2056-676X",
publisher = "Nature Publishing Group",
number = "1",

}

van Lennep, M, Singendonk, MMJ, Dall’Oglio, L, Gottrand, F, Krishnan, U, Terheggen-Lagro, SWJ, Omari, TI, Benninga, MA & van Wijk, MP 2019, 'Oesophageal atresia', NATURE REVIEWS DISEASE PRIMERS, vol. 5, no. 1, 26. https://doi.org/10.1038/s41572-019-0077-0

Oesophageal atresia. / van Lennep, Marinde; Singendonk, Maartje M. J.; Dall’Oglio, Luigi; Gottrand, Fréderic; Krishnan, Usha; Terheggen-Lagro, Suzanne W. J.; Omari, Taher I.; Benninga, Marc A.; van Wijk, Michiel P.

In: NATURE REVIEWS DISEASE PRIMERS, Vol. 5, No. 1, 26, 2019.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - Oesophageal atresia

AU - van Lennep, Marinde

AU - Singendonk, Maartje M. J.

AU - Dall’Oglio, Luigi

AU - Gottrand, Fréderic

AU - Krishnan, Usha

AU - Terheggen-Lagro, Suzanne W. J.

AU - Omari, Taher I.

AU - Benninga, Marc A.

AU - van Wijk, Michiel P.

PY - 2019

Y1 - 2019

N2 - Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated birth defects or anomalies, such as VACTERL association, trisomy 18 or 21 and CHARGE syndrome, occur in the majority of patients born with EA. Although several studies have revealed signalling pathways and genes potentially involved in the development of EA, our understanding of the pathophysiology of EA lags behind the improvements in surgical and clinical care of patients born with this anomaly. EA is treated surgically to restore the oesophageal interruption and, if present, ligate and divide the TEF. Survival is now ~90% in those born with EA with severe associated anomalies and even higher in those born with EA alone. Despite these achievements, long-term gastrointestinal and respiratory complications and comorbidities in patients born with EA are common and lead to decreased quality of life. Oesophageal motility disorders are probably ubiquitous in patients after undergoing EA repair and often underlie these complications and comorbidities. The implementation of several new diagnostic and screening tools in clinical care, including high-resolution impedance manometry, pH-multichannel intraluminal impedance testing and disease-specific quality of life questionnaires now provide better insight into these problems and may contribute to better long-term outcomes in the future.

AB - Oesophageal atresia (EA) is a congenital abnormality of the oesophagus that is caused by incomplete embryonic compartmentalization of the foregut. EA commonly occurs with a tracheo-oesophageal fistula (TEF). Associated birth defects or anomalies, such as VACTERL association, trisomy 18 or 21 and CHARGE syndrome, occur in the majority of patients born with EA. Although several studies have revealed signalling pathways and genes potentially involved in the development of EA, our understanding of the pathophysiology of EA lags behind the improvements in surgical and clinical care of patients born with this anomaly. EA is treated surgically to restore the oesophageal interruption and, if present, ligate and divide the TEF. Survival is now ~90% in those born with EA with severe associated anomalies and even higher in those born with EA alone. Despite these achievements, long-term gastrointestinal and respiratory complications and comorbidities in patients born with EA are common and lead to decreased quality of life. Oesophageal motility disorders are probably ubiquitous in patients after undergoing EA repair and often underlie these complications and comorbidities. The implementation of several new diagnostic and screening tools in clinical care, including high-resolution impedance manometry, pH-multichannel intraluminal impedance testing and disease-specific quality of life questionnaires now provide better insight into these problems and may contribute to better long-term outcomes in the future.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064531257&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/31000707

U2 - 10.1038/s41572-019-0077-0

DO - 10.1038/s41572-019-0077-0

M3 - Review article

VL - 5

JO - NATURE REVIEWS DISEASE PRIMERS

T2 - NATURE REVIEWS DISEASE PRIMERS

JF - NATURE REVIEWS DISEASE PRIMERS

SN - 2056-676X

IS - 1

M1 - 26

ER -

van Lennep M, Singendonk MMJ, Dall’Oglio L, Gottrand F, Krishnan U, Terheggen-Lagro SWJ et al. Oesophageal atresia. NATURE REVIEWS DISEASE PRIMERS. 2019;5(1). 26. https://doi.org/10.1038/s41572-019-0077-0